Back to Woodline Partners LP Woodline Partners LP

PTGXPTGX
18 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in PROTAGONIST THERAPEUTICS INC

Yes. Woodline Partners holds 1,414,173 shares of PTGX (Protagonist Therapeutics), worth $173.3M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Woodline Partners has held PTGX since Q1 2024, across 10 quarterly 13F filings. PTGX is 0.5% of Woodline Partners' reported 13F portfolio.

Current Value

$173.3M

Current Shares

1.4M

Total Value Change

+$156.5M

Total Shares Change

+921,186

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
1.4M
0.0%
$173.3M0.5%$122.58
0
2026-Q1
Increased
1.4M
+0.4%
$149.1M0.6%$105.40
43
2025-Q4
Decreased
1.4M
-2.0%
$123M0.5%$87.34
0
2025-Q3
Increased
1.4M
+51.9%
$95.5M0.4%$66.43
50
2025-Q2
Increased
946,884
+5.5%
$52.3M0.3%$55.27
37
2025-Q1
Increased
897,699
+54.2%
$43.4M0.3%$48.36
49
2024-Q4
Increased
582,327
+24.8%
$22.5M0.2%$38.60
42
2024-Q3
Decreased
466,518
-43.3%
$21M0.2%$45.00
0
2024-Q2
Increased
822,173
+29.1%
$28.5M0.3%$34.65
43
2024-Q1
New
636,956
-
$18.4M0.2%$28.93
47
2023-Q3
Exited
0
-100.0%
$00.0%$16.68
0
2023-Q2
Decreased
427,264
-30.9%
$11.8M0.1%$27.62
0
2023-Q1
Increased
618,615
+20.8%
$14.2M0.2%$23.00
40
2022-Q4
New
512,140
-
$5.6M0.1%$10.91
37
2022-Q3
Exited
0
-100.0%
$00.0%$8.43
0
2022-Q2
Decreased
388,637
-34.0%
$3.1M0.0%$7.91
0
2022-Q1
Increased
588,694
+19.4%
$13.9M0.2%$23.68
40
2021-Q4
New
492,987
-
$16.9M0.2%$34.20
47

Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used